DS
BHVN icon

David Shaw’s Biohaven BHVN Stock Holding History

David Shaw’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,100
Closed -$509K – 4557
2025
Q4 		$509K Buy
+45,100
New +$559K ﹤0.01% 3923

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's BHVN Position: Q2 2026 in Review

David Shaw increased its Biohaven (BHVN) stake by 47% in Q2 2026, buying an estimated $14.5M and bringing the position to 4,190,195 shares worth $62.4M. The position accounts for 0.03% of the portfolio, ranked #652.

David Shaw first reported a position in BHVN in Q4 2022 and has held it in 13 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • David Shaw held 4,190,195 shares of Biohaven worth $62.4M as of Q2 2026.
  • David Shaw bought 1,343,002 Biohaven shares in Q2 2026, an estimated $14.5M.
  • Biohaven made up 0.03% of David Shaw's portfolio in Q2 2026, its #652 holding.
  • David Shaw first reported a position in Biohaven in Q4 2022 and has held it in 13 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.